Invention Grant
- Patent Title: Agonist fusion protein for CD40 and OX40 and methods of stimulating the immune system
-
Application No.: US14763730Application Date: 2014-01-31
-
Publication No.: US10533054B2Publication Date: 2020-01-14
- Inventor: Mark L. Tykocinski , Matthew Charles Weber
- Applicant: THOMAS JEFFERSON UNIVERSITY
- Applicant Address: US PA Philadelphia
- Assignee: Thomas Jefferson University
- Current Assignee: Thomas Jefferson University
- Current Assignee Address: US PA Philadelphia
- Agency: Saul Ewing Arnstein & Lehr LLP
- Agent Kathryn Doyle; Jacque C. Young
- International Application: PCT/US2014/014200 WO 20140131
- International Announcement: WO2014/121099 WO 20140807
- Main IPC: C07K16/28
- IPC: C07K16/28 ; A61K39/395 ; C07K14/705
Abstract:
Provided is a fusion protein comprising an agonist for CD40 and an agonist for OX40. Compositions comprising the fusion protein and methods of use are also provided.
Public/Granted literature
- US20150368350A1 AGONIST FUSION PROTEIN FOR CD40 AND OX40 AND USES THEREOF Public/Granted day:2015-12-24
Information query
